Skip to content
Belgian Association for the Study of the Liver
  • Steering Committee|
  • Links|
  • Contact|
  • Register|
  • Login|
BASL
  • Home
  • About
  • Young BASL
  • News & Events
  • Forms & guidelines
  • Sponsors

TREATMENT OPTIONS AND DIAGNOSTIC CUT-OFFS FOR HCV IN BELGIUM

In Hepatitis C : cut-off’s elastography and biological testing for METAVIR F2-F3-F4, requirements to prescribe DAA, and treatment options in Belgium (update Januari 2019)

Available as PDF or PowerPoint

 Belgian HCV therapy guidance update january 2019.pptx
 Belgian HCV therapy guidance update january 2019.pdf
LINKS

Privacy policy

Cookie policy

BASL

Belgium Association for the Study of the Liver

Leuvensesteenweg 643, 1930 Nossegem

VAT NUMBER

0471.307.756

ACCOUNT NUMBER

IBAN BE69 0013 4462 1878